- Home
- GLNG vs LNTH Comparison
GLNG vs LNTH Comparison
Compare GLNG & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLNG
- LNTH
- Stock Information
- Founded
- GLNG 1946
- LNTH 1956
- Country
- GLNG Bermuda
- LNTH United States
- Employees
- GLNG N/A
- LNTH N/A
- Industry
- GLNG Marine Transportation
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GLNG Consumer Discretionary
- LNTH Health Care
- Exchange
- GLNG Nasdaq
- LNTH Nasdaq
- Market Cap
- GLNG 4.2B
- LNTH 3.6B
- IPO Year
- GLNG N/A
- LNTH 2015
- Fundamental
- Price
- GLNG $39.30
- LNTH $53.83
- Analyst Decision
- GLNG Strong Buy
- LNTH Strong Buy
- Analyst Count
- GLNG 3
- LNTH 6
- Target Price
- GLNG $51.17
- LNTH $85.50
- AVG Volume (30 Days)
- GLNG 1.4M
- LNTH 1.5M
- Earning Date
- GLNG 01-01-0001
- LNTH 11-05-2025
- Dividend Yield
- GLNG 2.54%
- LNTH N/A
- EPS Growth
- GLNG N/A
- LNTH N/A
- EPS
- GLNG N/A
- LNTH 3.77
- Revenue
- GLNG $268,899,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- GLNG $58.52
- LNTH N/A
- Revenue Next Year
- GLNG $1.39
- LNTH $3.24
- P/E Ratio
- GLNG N/A
- LNTH $14.27
- Revenue Growth
- GLNG N/A
- LNTH 5.75
- 52 Week Low
- GLNG $29.56
- LNTH $47.25
- 52 Week High
- GLNG $45.98
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- GLNG 38.53
- LNTH 50.57
- Support Level
- GLNG $39.89
- LNTH $49.75
- Resistance Level
- GLNG $41.65
- LNTH $54.43
- Average True Range (ATR)
- GLNG 0.96
- LNTH 1.51
- MACD
- GLNG -0.08
- LNTH 0.61
- Stochastic Oscillator
- GLNG 14.24
- LNTH 87.11
About GLNG Golar Lng Ltd
Golar LNG Ltd is a midstream LNG company that operates in the transportation, regasification, liquefaction, and trading of LNG. The segment in which the group operates includes Shipping, FLNG (Floating Liquefaction Natural Gas vessels), and Corporate and other. It generates maximum revenue from the FLNG segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.